JP4475943B2 - プロスタグランジン及びそれらの類縁体の製法 - Google Patents

プロスタグランジン及びそれらの類縁体の製法 Download PDF

Info

Publication number
JP4475943B2
JP4475943B2 JP2003500077A JP2003500077A JP4475943B2 JP 4475943 B2 JP4475943 B2 JP 4475943B2 JP 2003500077 A JP2003500077 A JP 2003500077A JP 2003500077 A JP2003500077 A JP 2003500077A JP 4475943 B2 JP4475943 B2 JP 4475943B2
Authority
JP
Japan
Prior art keywords
formula
compound
group
alkyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003500077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503354A (ja
JP2005503354A5 (enExample
Inventor
ケネス グリーンウッド,アラン
ムシャティ,デレク
ジョージ トンプソン,デビッド
ウィンハム クリソルド,デレク
Original Assignee
レゾリューション ケミカルズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by レゾリューション ケミカルズ リミテッド filed Critical レゾリューション ケミカルズ リミテッド
Publication of JP2005503354A publication Critical patent/JP2005503354A/ja
Publication of JP2005503354A5 publication Critical patent/JP2005503354A5/ja
Application granted granted Critical
Publication of JP4475943B2 publication Critical patent/JP4475943B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F295/00Macromolecular compounds obtained by polymerisation using successively different catalyst types without deactivating the intermediate polymer
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2003500077A 2001-05-24 2002-05-24 プロスタグランジン及びそれらの類縁体の製法 Expired - Fee Related JP4475943B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0112699.4A GB0112699D0 (en) 2001-05-24 2001-05-24 Process for the preparation of prostglandins and analogues thereof
PCT/GB2002/002462 WO2002096898A2 (en) 2001-05-24 2002-05-24 Process for the preparation of prostaglandins and analogues thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009278234A Division JP2010053149A (ja) 2001-05-24 2009-12-08 プロスタグランジン及びそれらの類縁体の製法

Publications (3)

Publication Number Publication Date
JP2005503354A JP2005503354A (ja) 2005-02-03
JP2005503354A5 JP2005503354A5 (enExample) 2006-01-05
JP4475943B2 true JP4475943B2 (ja) 2010-06-09

Family

ID=9915243

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003500077A Expired - Fee Related JP4475943B2 (ja) 2001-05-24 2002-05-24 プロスタグランジン及びそれらの類縁体の製法
JP2009278234A Pending JP2010053149A (ja) 2001-05-24 2009-12-08 プロスタグランジン及びそれらの類縁体の製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009278234A Pending JP2010053149A (ja) 2001-05-24 2009-12-08 プロスタグランジン及びそれらの類縁体の製法

Country Status (15)

Country Link
US (3) US20040249172A1 (enExample)
EP (2) EP2311820A1 (enExample)
JP (2) JP4475943B2 (enExample)
CN (2) CN1301986C (enExample)
AU (1) AU2002321396B2 (enExample)
BR (1) BR0209984A (enExample)
CA (1) CA2448088A1 (enExample)
GB (1) GB0112699D0 (enExample)
HU (1) HUP0400047A3 (enExample)
IL (1) IL159030A0 (enExample)
NO (1) NO329883B1 (enExample)
NZ (1) NZ529634A (enExample)
SK (1) SK14362003A3 (enExample)
WO (1) WO2002096898A2 (enExample)
ZA (1) ZA200308916B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US20090287003A1 (en) * 2005-09-29 2009-11-19 Jiang Xing Chen Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost
US7511168B2 (en) 2006-01-18 2009-03-31 Shih-Yi Wei Processes and intermediates for the preparations of prostaglandins
US8546114B2 (en) 2006-01-18 2013-10-01 Chirogate International Inc. Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom
EP2735566A1 (en) * 2006-02-07 2014-05-28 R-Tech Ueno, Ltd. Method for preparing prostaglandin derivative
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
US7642370B2 (en) * 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
US20090233830A1 (en) * 2008-03-14 2009-09-17 Penny Sue Dirr Automatic detergent dishwashing composition
EP2135860A1 (en) 2008-06-20 2009-12-23 Sandoz AG Improved process for the production of bimatoprost
EP2143712A1 (en) 2008-07-10 2010-01-13 Sandoz AG Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
IT1392492B1 (it) * 2008-12-24 2012-03-09 Ind Chimica Srl Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.
KR101045935B1 (ko) * 2009-03-11 2011-07-01 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법
US8519178B2 (en) * 2009-06-22 2013-08-27 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
CA2777290C (en) * 2009-10-16 2016-06-28 Cayman Chemical Company, Incorporated Process for the preparation of f-series prostaglandins
WO2011055377A1 (en) * 2009-11-05 2011-05-12 Biocon Limited A novel process for the preparation of prostaglandins and intermediates thereof
WO2011095990A2 (en) 2010-02-03 2011-08-11 Fdc Limited Process for the purification of prostaglandins and analogues thereof
EP2495235B1 (en) 2011-03-04 2015-08-05 Newchem S.p.A. Process for the synthesis of prostaglandins and intermediates thereof
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
TWI435752B (zh) * 2012-08-15 2014-05-01 Everlight Chem Ind Corp 使用製備型高效液相層析儀純化含氟之前列腺素之方法
US9115109B2 (en) 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
HU231214B1 (hu) 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására
CN104513186B (zh) * 2015-01-13 2016-10-05 宁波第二激素厂 一种光学纯的右旋氯前列醇钠的制备方法
HU231175B1 (hu) * 2015-12-04 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Tetszőleges, előre meghatározott minőségű Latanoprostene bunod előállítása gravitációs kromatográfiával
EP3950672A4 (en) * 2019-03-27 2023-01-11 Kyowa Pharma Chemical Co., Ltd. PROCESS FOR PRODUCTION OF PROSTAGLANDIN
CN112608294B (zh) * 2020-12-16 2021-10-26 西安国康瑞金制药有限公司 一种拉坦前列腺素的制备方法
WO2022138586A1 (ja) * 2020-12-23 2022-06-30 協和ファーマケミカル株式会社 幾何異性体の分離方法
CN115991691B (zh) * 2023-03-23 2023-05-16 西南交通大学 一种拉坦前列素中间体的制备方法及其用途
WO2025149165A1 (en) 2024-01-12 2025-07-17 Intervet International B.V. A PROCESS FOR PURIFICATION OF INTERMEDIATES OF PROSTAGLANDIN F2Αα COMPOUNDS AND ITS USE IN THE PREPARATION OF PROSTAGLANDIN F2α COMPOUNDS

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549688A (en) * 1967-02-16 1970-12-22 Gen Electric Process for the preparation of carboxylic acid esters
US3778450A (en) 1971-03-23 1973-12-11 Upjohn Co Certain bicyclic lactones
CA971957A (en) 1971-12-13 1975-07-29 Upjohn Company (The) PROCESS FOR PREPARING PROSTAGLANDIN E'S FROM PROSTAGLANDIN F.alpha.'S
US4100355A (en) 1972-09-15 1978-07-11 The Upjohn Company 8β,12α-PGE2 -type compounds
US3864387A (en) 1973-05-21 1975-02-04 Upjohn Co 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs
US3931279A (en) 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions
US4036832A (en) 1974-07-03 1977-07-19 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
DE2434133C2 (de) 1974-07-12 1987-03-19 Schering AG, 1000 Berlin und 4709 Bergkamen 15,15-Äthylendioxy-Prostansäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2517773A1 (de) * 1975-04-18 1976-10-28 Schering Ag Neue 11-oxo-prostaglandin-derivate und verfahren zu ihrer herstellung
US4158667A (en) * 1976-02-04 1979-06-19 The Upjohn Company 6-Keto PGF analogs
EP0059307A1 (de) 1981-02-26 1982-09-08 Grünenthal GmbH Verfahren zur Herstellung von 2-Oxabicyclo(3.3.0)octanderivaten und danach erhältliche Produkte
US4599353A (en) 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPS6137752A (ja) * 1984-07-30 1986-02-22 Kuraray Co Ltd 高度不飽和長鎖脂肪酸またはそのエステルの分離精製法
US4680415A (en) * 1985-06-24 1987-07-14 Hoffmann-La Roche Inc. Intermediates for 7-fluoro dihydro PGI compounds
US4943635A (en) 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
EP0394263B1 (en) 1987-09-04 1994-03-16 The Upjohn Company Process for production of prostaglandin intermediates
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE420857T1 (de) 1988-09-06 2009-01-15 Pfizer Health Ab Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
JP2855450B2 (ja) 1989-09-11 1999-02-10 小野薬品工業株式会社 プロスタグランジン誘導体の中間体の製造方法
SE9002596D0 (sv) 1990-08-08 1990-08-08 Pharmacia Ab A method for synthesis of prostaglandin derivatives
EP0472338A3 (en) * 1990-08-21 1993-05-19 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Method of manufacturing prostaglandin intermediate
JPH085873B2 (ja) 1990-08-21 1996-01-24 株式会社上野製薬応用研究所 プロスタグランジン中間体の製法
HU212570B (en) 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
US5223537A (en) * 1991-07-23 1993-06-29 Kabi Pharmacia Ab Method and composition for treatment of gastric and duodenal disorders
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
JP3207203B2 (ja) 1992-09-30 2001-09-10 株式会社上野製薬応用研究所 α,β−不飽和ケトンの製造法
DE4323331A1 (de) 1993-07-08 1995-01-12 Schering Ag Neue bicyclische Lactone
US6184250B1 (en) * 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
NL194919C (nl) * 1993-09-07 2003-07-04 Tno Werkwijze voor het oxideren van koolhydraten.
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5698733A (en) 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
ATE202557T1 (de) * 1996-11-12 2001-07-15 Alcon Lab Inc 15-fluoro-prostaglandine als augendrucksenkende mittel
SE9702681D0 (sv) 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
SE9702706D0 (sv) 1997-07-11 1997-07-11 Pharmacia & Upjohn Ab Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
WO1999012899A1 (en) 1997-09-09 1999-03-18 The Procter & Gamble Company A process for making prostaglandin f analogs
WO2000020386A1 (en) 1998-10-05 2000-04-13 Alcon Laboratories, Inc. Stannane synthesis of prostanoids
SE9900025D0 (sv) 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
WO2000040246A1 (en) 1999-01-08 2000-07-13 University Of Massachusetts Detection of human immunodeficiency virus
JP3501025B2 (ja) 1999-07-15 2004-02-23 松下電器産業株式会社 電気調理器
IL134241A (en) 2000-01-27 2006-06-11 Finetech Pharmaceutical Ltd Process for the preparation of latanoprost
AU2001233286B2 (en) 2000-02-01 2006-04-06 Cayman Chemical Company, Incorporated Internal 1,15-lactones of fluprostenol and related prostaglandin F2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
WO2001067816A1 (en) 2000-03-07 2001-09-13 Daimlerchrysler Ag Skin effect heating system for a structural member
WO2001087816A1 (en) * 2000-05-15 2001-11-22 Pharmacia & Upjohn Company Process and intermediates to prepare latanoprost
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
KR100581647B1 (ko) * 2001-07-17 2006-05-22 파마시아 앤드 업존 캄파니 엘엘씨 라타노프로스트 제조를 위한 방법 및 중간체

Also Published As

Publication number Publication date
JP2010053149A (ja) 2010-03-11
US20050272877A1 (en) 2005-12-08
GB0112699D0 (en) 2001-07-18
US7268239B2 (en) 2007-09-11
AU2002321396B2 (en) 2007-10-18
CA2448088A1 (en) 2002-12-05
BR0209984A (pt) 2004-04-06
WO2002096898A3 (en) 2003-03-20
JP2005503354A (ja) 2005-02-03
NZ529634A (en) 2004-11-26
CN1533385A (zh) 2004-09-29
ZA200308916B (en) 2007-11-28
US7498458B2 (en) 2009-03-03
WO2002096898A2 (en) 2002-12-05
US20040249172A1 (en) 2004-12-09
NO329883B1 (no) 2011-01-17
SK14362003A3 (sk) 2004-05-04
CN101003503A (zh) 2007-07-25
HUP0400047A3 (en) 2007-05-02
EP1389198A2 (en) 2004-02-18
NO20035162D0 (no) 2003-11-20
US20050261374A1 (en) 2005-11-24
HUP0400047A2 (hu) 2004-04-28
IL159030A0 (en) 2004-05-12
EP2311820A1 (en) 2011-04-20
CN1301986C (zh) 2007-02-28

Similar Documents

Publication Publication Date Title
JP4475943B2 (ja) プロスタグランジン及びそれらの類縁体の製法
AU2002321396A1 (en) Process for the preparation of prostaglandins and analogues thereof
KR100437873B1 (ko) 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질
JP2005503354A5 (enExample)
JP6440896B2 (ja) ベラプロストを作製するための方法
WO2010109476A2 (en) Improved process for the preparation of prostaglandins and analogues thereof
KR101522218B1 (ko) 프로스타글란딘 제조를 위한 방법 및 중간체
KR20170028990A (ko) 프로스타글란딘 및 프로스타글란딘 유사체를 생산하기 위한 2-치환된-4-옥시-사이클로펜트-2-엔-1-온에 대한 비닐붕소 화합물의 금속-촉매화된 비대칭 1,4-콘주게이트 첨가
JP7680058B2 (ja) カルバプロスタサイクリン類縁体の製造のための方法及び中間体
JPWO1998021179A1 (ja) プロスタグランジン類の製造方法
TW202248197A (zh) 製備苯并前列環素類似物之方法及中間物,及由其製得之苯并前列環素類似物
AU8447891A (en) Novel prostaglandin i2 derivatives
DK146025B (da) Analogifremgangsmaade til fremstilling af trans-delta2-prostaglandinanaloge
JPH0651676B2 (ja) (5e)−プロスタグランジンe▲下2▼類の製造法
JPH0470297B2 (enExample)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050414

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050414

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20061107

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20061107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20061107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081219

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090130

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090226

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090811

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091208

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100209

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100309

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 3

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140319

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees